WO2009140466A3 - Linezolid co-crystals - Google Patents

Linezolid co-crystals Download PDF

Info

Publication number
WO2009140466A3
WO2009140466A3 PCT/US2009/043903 US2009043903W WO2009140466A3 WO 2009140466 A3 WO2009140466 A3 WO 2009140466A3 US 2009043903 W US2009043903 W US 2009043903W WO 2009140466 A3 WO2009140466 A3 WO 2009140466A3
Authority
WO
WIPO (PCT)
Prior art keywords
linezolid
crystals
preparing
processes
crystal former
Prior art date
Application number
PCT/US2009/043903
Other languages
French (fr)
Other versions
WO2009140466A2 (en
Inventor
Surya Narayana Devarakonda
Ram Thaimattam
Vamsee Krishna Muppidi
Sundara Lakshmi Kanniah
Naga Kiran Duggirala
Original Assignee
Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc. filed Critical Dr. Reddy's Laboratories Ltd.
Publication of WO2009140466A2 publication Critical patent/WO2009140466A2/en
Publication of WO2009140466A3 publication Critical patent/WO2009140466A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2

Abstract

Co-crystals of linezolid, comprising linezolid and a co-crystal former, and processes for preparing them.
PCT/US2009/043903 2008-05-14 2009-05-14 Linezolid co-crystals WO2009140466A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1187CH2008 2008-05-14
IN1187/CHE/2008 2008-05-14
US7634408P 2008-06-27 2008-06-27
US61/076,344 2008-06-27

Publications (2)

Publication Number Publication Date
WO2009140466A2 WO2009140466A2 (en) 2009-11-19
WO2009140466A3 true WO2009140466A3 (en) 2010-03-04

Family

ID=41319332

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/043903 WO2009140466A2 (en) 2008-05-14 2009-05-14 Linezolid co-crystals

Country Status (1)

Country Link
WO (1) WO2009140466A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011029460A1 (en) * 2009-09-09 2011-03-17 Synthon B.V. Nonhygroscopic linezolid salts
WO2011050826A1 (en) * 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
US9173391B2 (en) * 2009-11-06 2015-11-03 Basf Se Crystalline complexes of 4-hydroxy benzoic acid and selected pesticides
RS60440B1 (en) * 2013-07-29 2020-07-31 Servier Lab Complexes of agomelatine and sulphonic acids, method for preparing same and pharmaceutical compositions containing them

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) * 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
WO2005035530A1 (en) * 2003-10-16 2005-04-21 Symed Labs Limited A novel crystalline form of linezolid
WO2006110155A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof
US20070015753A1 (en) * 2005-07-15 2007-01-18 Glenmark Pharmaceuticals Limited Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4-(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide
WO2007026369A1 (en) * 2005-08-29 2007-03-08 Symed Labs Limited A novel amorphous form of linezolid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) * 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
WO2005035530A1 (en) * 2003-10-16 2005-04-21 Symed Labs Limited A novel crystalline form of linezolid
WO2006110155A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof
US20070015753A1 (en) * 2005-07-15 2007-01-18 Glenmark Pharmaceuticals Limited Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4-(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide
WO2007026369A1 (en) * 2005-08-29 2007-03-08 Symed Labs Limited A novel amorphous form of linezolid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MACCARONI, E. ET AL.: "Polymorphism of linezolid: A combined single-cystal, powder diffraction and NMR study", INTERNATIONAL JOURNAL OF PHARMACEUTICS., vol. 351, no. 1-2, 2008, pages 144 - 151 *

Also Published As

Publication number Publication date
WO2009140466A2 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
WO2012014076A3 (en) Liver organoid, uses thereof and culture method for obtaining them
MX2012012627A (en) Processes for preparing linezolid.
WO2013052913A3 (en) Methods and processes for non-invasive assessment of genetic variations
WO2012084126A3 (en) Formulation of lacosamide
PL2571975T3 (en) Device for preparing tissue, particularly adipose tissue.
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
WO2012059441A3 (en) Method for preparing substituted isoxazoline compounds and their precursors 4-chloro, 4-bromo- or 4-iodobenzaldehyde oximes
WO2010117738A3 (en) Solid state forms of sitagliptin salts
WO2011060213A3 (en) Preparation of sitagliptin and salts thereof
WO2014041560A3 (en) Process for the preparation of teneligliptin
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
GEP20156397B (en) Process for the preparation of a rivaroxaban and intermediates formed in said process
WO2011157390A3 (en) Process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
WO2011025932A3 (en) Preparation of sitagliptin and salts thereof
RS58822B1 (en) A sheet, a method of making and using a sheet as a lid for packages.
WO2012131707A3 (en) Crystalline form of bortezomib, preparation method and pharmaceutical composition there f
WO2010116342A8 (en) Non-steroidal compounds for androgen receptor modulation, processes for the preparation and uses thereof
IL208019A0 (en) Process for the preparation of 2-amino-2-[2-(4-c3-c21-alkyl-phenyl) ethyl) propane-1, 3-diols
WO2009140466A3 (en) Linezolid co-crystals
WO2011095269A3 (en) Directly compressible magnesium hydroxide carbonate
WO2010034976A3 (en) Co-crystals
WO2010117979A3 (en) Serotonin and norepinephrine reuptake inhibitor
EP2883870B8 (en) Method for producing 1,4-benzoxazine compound
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
MX349563B (en) Pharmaceutical formulation of nanonised fenofibrate.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09747548

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09747548

Country of ref document: EP

Kind code of ref document: A2